10.3389/fcell.2021.813668 42
Purpose-built for physicians Long-term weight regain minimal with tirzepatide for adults with obesity, prediabetes Key takeaways: Adults with obesity and prediabetes had a mean weight regain of 3.7% at 176 weeks after reaching their nadir weight loss
[1] [2] It works as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, enhancing insulin secretion, suppressing glucagon release, slowing gastric emptying, and reducing appetite
[33:09] C You mean because this was a positive trial, so we're looking for sources of chance or bias
Patients who benefit from thyroid replacement therapy at our practice include those diagnosed with primary hypothyroidism, which can result from autoimmune conditions like Hashimotos thyroiditis, surgical removal of the thyroid (thyroidectomy), or damage following radiation treatments for cancers of the head or neck